{"id":"https://openalex.org/W1963409105","doi":null,"title":"Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.","display_name":"Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.","publication_year":2000,"publication_date":"2000-09-01","ids":{"openalex":"https://openalex.org/W1963409105","mag":"1963409105","pmid":"https://pubmed.ncbi.nlm.nih.gov/10999754"},"language":"en","primary_location":{"id":"pmid:10999754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10999754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040006704","display_name":"Kate Clarke","orcid":"https://orcid.org/0009-0006-0978-4798","observed_orcids":["https://orcid.org/0009-0006-0978-4798"]},"institutions":[{"id":"https://openalex.org/I196064397","display_name":"Ludwig Cancer Research","ror":"https://ror.org/05923xh51","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I196064397","https://openalex.org/I4210150094"]},{"id":"https://openalex.org/I4210123010","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02vh2pt65","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210123010","https://openalex.org/I4210150094"]}],"countries":["AU","BE"],"is_corresponding":false,"raw_author_name":"K Clarke","raw_affiliation_strings":["Tumour Targeting Program, Ludwig Institute for Cancer Research, Melbourne Branch, Austin and Repatriation Medical Centre, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumour Targeting Program, Ludwig Institute for Cancer Research, Melbourne Branch, Austin and Repatriation Medical Centre, Victoria, Australia","institution_ids":["https://openalex.org/I196064397","https://openalex.org/I4210123010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034686081","display_name":"Fook-Thean Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F T Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002401816","display_name":"Martin W. Brechbiel","orcid":"https://orcid.org/0000-0002-4012-1400","observed_orcids":["https://orcid.org/0000-0002-4012-1400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M W Brechbiel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112271697","display_name":"Fiona E. Smyth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F E Smyth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089344430","display_name":"Lloyd J. Old","orcid":"https://orcid.org/0000-0002-2333-7445","observed_orcids":["https://orcid.org/0000-0002-2333-7445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L J Old","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078312966","display_name":"Andrew Mark Scott","orcid":"https://orcid.org/0000-0002-6656-295X","observed_orcids":["https://orcid.org/0000-0002-6656-295X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Scott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5822,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.88125289,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"9","first_page":"3621","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/131i-labeled-antibody","display_name":"131I-labeled antibody","score":0.8629999756813049},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9760000109672546},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8169999718666077},{"id":"https://openalex.org/keywords/mcf-7-xenografts","display_name":"MCF-7 xenografts","score":0.8790000081062317},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6480000019073486},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7739999890327454},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.9712677597999573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7182353734970093},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6852725148200989},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6085940599441528},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5687012076377869},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4763745963573456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44570082426071167},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.43095147609710693},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41985446214675903},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4150035083293915},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40878280997276306},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3822934627532959},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29560571908950806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28310075402259827}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004307","descriptor_name":"Dose-Response Relationship, Radiation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007983","descriptor_name":"Lewis Blood Group Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10999754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10999754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:1963409105","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10999754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W16661828","https://openalex.org/W36801553","https://openalex.org/W1515560810","https://openalex.org/W1598821044","https://openalex.org/W1605645272","https://openalex.org/W1608334591","https://openalex.org/W1832002274","https://openalex.org/W1893651774","https://openalex.org/W1915538262","https://openalex.org/W1969835334","https://openalex.org/W1988964865","https://openalex.org/W2026036045","https://openalex.org/W2031349795","https://openalex.org/W2033785962","https://openalex.org/W2042585130","https://openalex.org/W2043319149","https://openalex.org/W2058426435","https://openalex.org/W2068391687","https://openalex.org/W2074580909","https://openalex.org/W2096014886","https://openalex.org/W2098553225","https://openalex.org/W2112397375","https://openalex.org/W2131688160","https://openalex.org/W2140636685","https://openalex.org/W2154027407","https://openalex.org/W2171865821","https://openalex.org/W2413883045","https://openalex.org/W2414583284"],"related_works":["https://openalex.org/W2103399362","https://openalex.org/W2149549005","https://openalex.org/W2000273596","https://openalex.org/W7099575723","https://openalex.org/W2074580909","https://openalex.org/W2171865821","https://openalex.org/W2154932340","https://openalex.org/W2112397375","https://openalex.org/W1431696895","https://openalex.org/W4302031722"],"abstract_inverted_index":{"Monoclonal":[0],"antibody":[1,49,62,85,156],"therapy":[2,217],"may":[3],"provide":[4],"new":[5,227],"treatment":[6,116,189,211],"options":[7],"in":[8,63,69,106,111,178,209],"the":[9,112,126,193,210],"management":[10],"of":[11,44,56,66,83,95,128,153,162,167,172,180,195,206,212,224],"metastatic":[12],"breast":[13,76,213],"cancer":[14,77,119],"by":[15,24,35],"selectively":[16],"targeting":[17],"tumors":[18],"and":[19,58,138,144,157,169,197,220],"producing":[20,36],"a":[21,64,70,151,202],"therapeutic":[22,204],"effect,":[23],"delivering":[25],"radiation":[26],"or":[27,34,192],"other":[28],"toxins":[29],"directly":[30],"to":[31,108,124,135],"tumor":[32,103,176],"cells,":[33],"an":[37,121],"intrinsic":[38],"immune":[39],"inflammatory":[40],"response.":[41],"The":[42,79,140,165],"effect":[43],"131I-labeled":[45,84,154],"humanized":[46],"anti-Lewis(y)":[47],"monoclonal":[48],"3S193":[50],"(hu3S193)":[51],"was":[52,146],"compared":[53],"with":[54,187,218],"that":[55,98],"placebo":[57],"radiolabeled":[59,207],"huA33":[60],"control":[61,115],"series":[65],"radioimmunotherapy":[67,143],"experiments":[68],"MCF-7":[71],"xenografted":[72],"BALB/c":[73],"nude":[74],"mouse":[75],"model.":[78],"maximum":[80],"tolerated":[81],"dose":[82,92],"occurred":[86],"at":[87,90],"200":[88],"microCi/mouse,":[89],"which":[91],"level":[93],"three":[94],"six":[96],"mice":[97],"received":[99],"131I-hu3S193":[100,173],"showed":[101],"significant":[102,175],"growth":[104],"inhibition":[105,177],"contrast":[107],"no":[109,183],"responses":[110,184],"comparable":[113],"131I-huA33":[114],"arm.":[117],"Breast":[118],"is":[120],"ideal":[122],"model":[123],"test":[125],"efficacy":[127],"combined":[129],"modalities":[130],"given":[131],"its":[132],"known":[133],"sensitivity":[134],"both":[136],"radiotherapy":[137],"chemotherapy.":[139],"synergy":[141],"between":[142],"chemotherapy":[145],"therefore":[147],"also":[148],"explored":[149],"using":[150,159],"combination":[152,166,194,216],"hu3S193":[155,208],"Taxol":[158,168,196],"subtherapeutic":[160],"doses":[161],"each":[163],"agent.":[164,228],"100":[170],"microCi":[171],"produced":[174],"80%":[179],"mice,":[181],"whereas":[182],"were":[185],"seen":[186],"either":[188],"modality":[190],"alone":[191],"131I-huA33.":[198],"These":[199],"results":[200],"support":[201],"potential":[203],"role":[205],"cancer,":[214],"including":[215],"Taxol,":[219],"warrants":[221],"further":[222],"investigation":[223],"this":[225],"promising":[226]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}